Willow Biosciences is the result of a three-way merger between University of Calgary spinout Epimeron, BioCan Technologies and CSE-listed Makena Resources.

Epimeron, a Canada-based biotechnology spinout of University of Calgary, and cannabis producer BioCan Technologies have completed their reverse merger with exploration company Makena Resources to form Willow Biosciences.
The new business listed on the Canadian Securities Exchange on Monday after completing a private placement of $29m, with cannabis-focused private equity firm Tuatara Capital supplying $21m. Makena was previously listed on the same stock exchange.
Willow Biosciences will focus on cannabinoid biosynthetic production through all stages of development, from…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
email
Linked in